Strides Pharma Science Limited — Important, 16-06-2025: Sale or disposal

Strides Pharma has announced a board meeting to approve the sale of its entire stake in dormant subsidiary Strides CIS Limited, Cyprus, to Mr. Sarvesh Bhargava and Mrs. Ranjana Bhargava for a nominal consideration of USD 100. The subsidiary had no revenue and minimal net worth as of March 2025. This move aligns with Strides Pharma’s plan to simplify its group structure by divesting non-operational entities.